ArticleJournal of medicinal chemistry2022

Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.

Tord Inghardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.